X0306 4 2022-02-25 0 0001420800 Colfax CORP CFX 0001357529 Hix Christopher M 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808 0 1 0 0 EVP, Chief Financial Officer Common stock, par value $.001 2022-02-25 4 S 0 2079 42.18 D 108509 D Common stock, par value $.001 2022-02-25 4 A 0 67915 0.00 A 176424 D Common stock, par value $.001 2022-02-28 4 S 0 19330 40.113 D 157094 D Common stock, par value $.001 2022-02-28 4 S 0 11777 41.179 D 145317 D Common stock, par value $.001 2022-02-28 4 S 0 100 41.72 D 145217 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission ("SEC") on April 1, 2021. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.69 to $40.67, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.69 to $41.54, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4. /s/ Bradley Tandy, Attorney-in-Fact 2022-03-01